![[ICO]](/icons/blank.gif){kind=icon}
![[PARENTDIR]](/icons/back.gif){kind=icon}
![[IMG]](/icons/image2.gif){kind=icon}
![[ ]](/icons/layout.gif){kind=icon}
| Name | Last modified | Size | Description |
|---|---|---|---|---|
| Parent Directory | - | ||
| IMG_7294-1-60x60.jpg | 2025-10-01 14:49 | 2.1K | |
| IMG_7294-60x60.jpg | 2025-10-01 14:00 | 2.1K | |
| IMG_7294-1-110x80.jpg | 2025-10-01 14:55 | 3.8K | |
| IMG_7294-110x80.jpg | 2025-10-01 14:09 | 3.8K | |
| IMG_7294-1-120x120.jpg | 2025-10-01 14:49 | 5.1K | |
| IMG_7294-120x120.jpg | 2025-10-01 14:00 | 5.1K | |
| bulletin-oct-150x150..> | 2025-10-27 10:31 | 5.4K | |
| EFDA-HQ-150x150.jpg | 2025-10-02 12:30 | 6.9K | |
| EFDA-HQ-1-150x150.jpg | 2025-10-02 12:32 | 6.9K | |
| IMG_7294-1-150x150.jpg | 2025-10-01 14:46 | 7.3K | |
| IMG_7294-150x150.jpg | 2025-10-01 13:46 | 7.3K | |
| 20250919_132310-150x..> | 2025-10-01 13:54 | 7.7K | |
| group2-1-150x150.jpg | 2025-10-01 13:55 | 8.3K | |
| group2-150x150.jpg | 2025-10-01 13:35 | 8.3K | |
| bulletin-oct-300x95.jpg | 2025-10-27 10:31 | 9.0K | |
| IMG_7294-1-220x160.jpg | 2025-10-01 14:55 | 11K | |
| IMG_7294-220x160.jpg | 2025-10-01 14:09 | 11K | |
| 20250919_132310-300x..> | 2025-10-01 13:54 | 14K | |
| IMG_7294-1-300x169.jpg | 2025-10-01 14:46 | 15K | |
| IMG_7294-300x169.jpg | 2025-10-01 13:46 | 15K | |
| group2-1-300x150.jpg | 2025-10-01 13:55 | 15K | |
| group2-300x150.jpg | 2025-10-01 13:35 | 15K | |
| EFDA-HQ-300x202.jpg | 2025-10-02 12:30 | 17K | |
| EFDA-HQ-1-300x202.jpg | 2025-10-02 12:32 | 17K | |
| bulletin-oct-650x205..> | 2025-10-27 13:29 | 26K | |
| bulletin-oct-600x300..> | 2025-10-27 13:34 | 29K | |
| bulletin-oct-768x242..> | 2025-10-27 10:31 | 31K | |
| bulletin-oct.jpg | 2025-10-27 10:31 | 42K | |
| bulletin-oct-951x299..> | 2025-10-27 13:29 | 43K | |
| IMG_7294-1-650x366.jpg | 2025-10-01 15:40 | 52K | |
| IMG_7294-650x366.jpg | 2025-10-01 14:19 | 52K | |
| 20250919_132310-768x..> | 2025-10-01 13:54 | 61K | |
| group2-1-768x383.jpg | 2025-10-01 13:55 | 65K | |
| group2-768x383.jpg | 2025-10-01 13:35 | 65K | |
| IMG_7294-1-768x432.jpg | 2025-10-01 14:46 | 67K | |
| IMG_7294-768x432.jpg | 2025-10-01 13:46 | 67K | |
| IMG_7294-1-728x485.jpg | 2025-10-01 14:51 | 68K | |
| IMG_7294-728x485.jpg | 2025-10-01 14:11 | 68K | |
| EFDA-HQ-768x517.jpg | 2025-10-02 12:30 | 79K | |
| EFDA-HQ-1-768x517.jpg | 2025-10-02 12:32 | 84K | |
| IMG_7294-1-728x728.jpg | 2025-10-01 14:49 | 85K | |
| IMG_7294-728x728.jpg | 2025-10-01 14:09 | 85K | |
| 20250919_132310-1024..> | 2025-10-01 13:54 | 99K | |
| group2-1-1024x511.jpg | 2025-10-01 13:55 | 99K | |
| group2-1024x511.jpg | 2025-10-01 13:35 | 99K | |
| IMG_7294-1-1024x576.jpg | 2025-10-01 14:46 | 104K | |
| IMG_7294-1024x576.jpg | 2025-10-01 13:46 | 104K | |
| EFDA-HQ-1024x689.jpg | 2025-10-02 12:30 | 124K | |
| IMG_7294-1-1092x728.jpg | 2025-10-01 14:51 | 126K | |
| IMG_7294-1092x728.jpg | 2025-10-01 14:11 | 126K | |
| IMG_7294-1-1300x732.jpg | 2025-10-01 15:40 | 132K | |
| EFDA-HQ-1-1200x620.jpg | 2025-10-02 12:35 | 135K | |
| EFDA-HQ-1-1024x689.jpg | 2025-10-02 12:32 | 135K | |
| IMG_7294-1300x732.jpg | 2025-10-01 14:19 | 151K | |
| IMG_7294-1-1092x1092..> | 2025-10-01 14:50 | 156K | |
| IMG_7294-1092x1092.jpg | 2025-10-01 14:09 | 156K | |
| group2-1.jpg | 2025-10-01 13:55 | 188K | |
| group2.jpg | 2025-10-01 13:35 | 188K | |
| EFDA-HQ.jpg | 2025-10-02 12:30 | 191K | |
| EFDA-HQ-1-2400x1240.jpg | 2025-10-02 12:35 | 409K | |
| To-All-Market-Author..> | 2025-10-10 17:01 | 458K | |
| ረቂቅ-ተላላá..> | 2025-10-17 11:14 | 804K | |
| GVP-Guidline.pdf | 2025-10-14 10:35 | 967K | |
| IMG_7294-7008x3504.jpg | 2025-10-01 14:09 | 1.3M | |
| 20250919_132310.jpg | 2025-10-01 13:54 | 2.2M | |
| IMG_7294-1-7008x3504..> | 2025-10-01 14:53 | 2.2M | |
| Medicine-Information..> | 2025-10-27 10:30 | 2.3M | |
| PV-newsletter-Q1-Sep..> | 2025-10-20 17:07 | 3.3M | |
| IMG_7294-1.jpg | 2025-10-01 14:46 | 4.6M | |
| IMG_7294.jpg | 2025-10-01 13:46 | 4.6M | |
| EFDA-HQ-1.jpg | 2025-10-02 12:31 | 5.0M | |
